title: Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges.
abstract: Hypoglycemia in people with insulin-treated type 2 diabetes can be a limiting factor for management and a barrier to optimizing glycemic control. Even mild episodes of hypoglycemia can affect an individual's quality of life, and fear of hypoglycemia can lead to underinsulinization. This article explores the prevalence and consequences of hypoglycemia in people with type 2 diabetes with a focus on those who use basal insulins, offering strategies for prevention and management. It also discusses the benefits and challenges associated with new basal insulins, and their potential role in reducing hypoglycemia risk.
authors.affiliation: Charles H. Best Diabetes Centre, Ajax, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Ian
authors.initials: I
authors.lastname: Blumer
authors.affiliation: Diabetes Education Centre, University of British Columbia, Vernon, British Columbia, Canada. Electronic address: maureen.clement@interiorhealth.ca.
authors.forename: Maureen
authors.initials: M
authors.lastname: Clement
mesh_terms: D001786:Blood Glucose / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin
keywords: basal insulin; hypoglycemia; management; type 2 diabetes